SPX3,787.50+4.22 0.11%
DIA302.66-0.13 -0.04%
IXIC11,203.91+55.28 0.50%

-- Valeo Pharma Brief: Reports Net loss of $4.7 million for Q3-22 compared to $3.0 million for Q3-21

-- Valeo Pharma Brief: Reports Net loss of $4.7 million for Q3-22 compared to $3.0 million for Q3-21

MT Newswires · 09/13/2022 13:22

Please log in to view news